FDA approves Phase II trial for obesity-treating drug pemvidutide
The Food and Drug Administration (FDA) has approved a Phase II clinical trial for investigational obesity-treating drug pemvidutide. The...
FDA approves Phase II trial for obesity-treating drug pemvidutide
Type 1 diabetics should be screened regularly for obesity and chronic kidney disease
NTU researchers use gel and infrared light to tackle obesity
Oestrogen-regulated brain circuit helps females control obesity
Weight loss prior to fertility treatment may not increase births for women with obesity
MRI expands imaging access for patients with severe obesity
Investigational drug mimics beneficial effects of fasting in mice